Claim Missing Document
Check
Articles

Found 2 Documents
Search

Assessing Patient Satisfaction and Sociodemographic Determinants in Outpatient Pharmaceutical Care Dian Ayu Juwita; Chofifah Putri Isnania Syaiful; Dita Permatasari
Pharmaceutical and Biomedical Sciences Journal (PBSJ) Vol. 8 No. 1 (2026)
Publisher : Pharmacy Department, Faculty of Health Sciences, UIN Syarif Hidayatullah Jakarta, Indonesia

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.15408/pbsj.v8i1.51282

Abstract

Abstract: Patient satisfaction is an important indicator of pharmaceutical service quality, reflecting the interaction between healthcare providers and patients. The shift from drug-oriented to patient-oriented care requires healthcare professionals to improve service quality to meet patient needs and expectations. This study aimed to evaluate patient satisfaction with pharmaceutical services at the Outpatient Pharmacy of Semen Padang Hospital and its relationship with sociodemographic characteristics, including gender, age, education, occupation, and payment type. This study used a descriptive quantitative method with a cross-sectional approach using the Larson questionnaire as the research instrument. Data were analyzed using the Chi-square and Spearman tests. The study involved 391 patients who met the inclusion criteria at the Outpatient Pharmacy of Semen Padang Hospital. Most respondents were female (67.3%), adults (81.1%), had a high school education (37.1%), were unemployed (65.7%), and used BPJS insurance (82.1%). Overall, patient satisfaction with pharmaceutical services was categorized as “satisfied” with a mean score of 3.87. The Friendly Explanation dimension showed a higher score (3.95) than the Managing Therapy dimension (3.77). Gender, age, and occupation did not affect patient satisfaction (p>0.05), while education and payment type affected patient satisfaction (p<0.05). Overall, patients at the Outpatient Pharmacy of Semen Padang Hospital were satisfied with the pharmaceutical services provided, indicating good service quality and positive patient perceptions toward pharmaceutical care.                                                                                                                                                       Keywords: Outpatient Pharmacy, Patient Satisfaction, Pharmacy Services, Sociodemographic Characteristics
Comparative Economic and Clinical Utility of Adding Candesartan for Hypertension Management Najmiatul Fitria; Thang Nguyen; Afifah Machlaurin; Nabila Al Rizka; Dian Ayu Juwita
JSFK (Jurnal Sains Farmasi & Klinis) Vol 11 No 2 (2024): J Sains Farm Klin 11(2), August 2024
Publisher : Fakultas Farmasi Universitas Andalas

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.25077/jsfk.11.2.111-117.2024

Abstract

Introduction: Antihypertensive drugs require high costs because they are used over a long period. Therefore, consideration is needed in drug selection requirements, effectiveness, and price. This study aimed to see the beneficial results of hypertension therapy and the non-medical costs incurred by patients using cost-utility analysis (CUA). Method: This research was a prospective study. The incremental Cost-Utility Ratio (ICUR) of antihypertensive treatment was calculated using cost-utility data obtained through EQ-5D-5L questionnaires from outpatients at Universitas Andalas Hospital in January- March 2023 who met the inclusion and exclusion criteria. The costs used were from a patient perspective, consisting of direct medical and non-medical costs. This study compared standard treatment (amlodipine) with the addition of candesartan. Results: The number of respondents in this study was 67, consisting of 23 respondents (34.33%) using amlodipine alone and 44 respondents (65.67%) using the amlodipine-candesartan combination. The ICUR value obtained was IDR7,318,674/QALY. The difference in the average utility value of the amlodipine-candesartan combination with amlodipine alone is -0.02, and the difference in cost is -IDR12,224. Based on the cost-utility diagram, the amlodipine-candesartan combination group is included in the southwest quadrant (quadrant III), which illustrates that the cost required for the amlodipine-candesartan combination group is lower than the cost of the amlodipine single treatment group and the outcome is also not better (slightly lower or the same). Conclusion: It was recommended to prioritize using amlodipine alone for hypertension management, as it provides similar outcomes to the amlodipine-candesartan combination while incurring lower costs.